Results 261 to 270 of about 98,145 (299)
Some of the next articles are maybe not open access.
Second-Generation Anti-HCV Tests Predict Infectivity
Vox Sanguinis, 1992AbstractTwenty‐four blood donors found positive for the first‐generation hepatitis C antibody (anti‐HCV) test (Ortho EIA‐I) and 88 of their recipients over the period from 1972 to 1990 were retrospectively investigated with different first‐and second‐generation anti‐HCV tests.
J, Larsen, K, Skaug, A, Maeland
openaire +2 more sources
Anti-HCV et hémoglobinopathies
Revue Française de Transfusion et d'Hémobiologie, 1990B, Mattlinger, A M, Couroucé, R, Girot
openaire +2 more sources
Salivary anti-HCV as a marker of serum anti-HCV. A followup cohort study
Journal of Hepatology, 2001E. Sikuler +5 more
openaire +2 more sources
Epidemiology of anti-HCV antibodies in France
1992The aim of this large survey which covered 173,038 unselected blood donors, was to determine the seroprevalence of anti-HCV antibodies and surrogate markers (ALT and anti-HBc) in France. The results revealed a frequency of 0.63% of anti-HCV positive donors.
O. Agulles, C. Janot
openaire +1 more source
Prevalence of anti-HCV antibodies in Cameroon
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991Mencarini P +6 more
openaire +3 more sources
Impact of anti HCV (+) on renal transplantation
Transplantation Proceedings, 2000D J, Han +4 more
openaire +2 more sources
[Anti HCV drugs--ribavirin, telaprevir].
Nihon rinsho. Japanese journal of clinical medicine, 2012The goal of treatment of chronic hepatitis C is the elimination of HCV. Ribavirin and telaprevir are currently used with interferon. In patients with genotype 2 HCV, PEG-IFN+ RBV combination therapy is very effective, but in patients with genotype 1, only SVR can be achieved in only approximately 50%. Furthermore in genotype 1, viral factors i.e. ISDR,
Minoru, Sakamoto, Nobuyuki, Enomoto
openaire +1 more source
Performance of VIDAS® anti-HCV as a second-line test for the detection of anti-HCV antibodies
2014OBJECTIVES:Detection of specific antibodies is crucial for routine diagnosis of Hepatitis C virus (HCV) infection. Nowadays, many commercial tests based on chemiluminescence technology are available as highsensitive screening methods. In case of weak reactivity on first-line assays, further investigations are required to discriminate true-positivity ...
Furlini, G +5 more
openaire +1 more source